Editor’s note: Geoffrey Woo and Michael Brandt are cofounders of Nootrobox, an e-commerce nootropics company.
Biohacking and transhumanist advances (including nootropics, extended longevity, cybernetic implants, better behavioral and genetic self-understanding) will materially advance our quality of life and productivity in the coming decade, but we need to be thoughtful about the potential social and ethical pitfalls as we transform. Google Trends shows a marked uptick in searches for “nootropics” and related biohacking fields, so now is the time to have the conversation about the direction we’re headed.
Digital products and companies are not just changing the way we live our lives, but also playing larger and more influential roles in public policy and governance. This trend of the technology industry driving broader social policy will perhaps be even greater with biohacking companies as their product innovations begin to alter and transform what it means to be human
View original post 858 more words